vimarsana.com

Page 184 - சர்வதேச நிதி புகாரளித்தல் தரநிலைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Circa Enterprises: Circa Reports Sales and Operating Results for the First Quarter Ended March 31, 2021

Circa Enterprises: Circa Reports Sales and Operating Results for the First Quarter Ended March 31, 2021 Summary of first quarter operating results: Q1 2021 sales of $8.1 million, an increase of $1.0 million or 14.5% from Q1 2020 sales of $7.1 million Net income and comprehensive income of $163,000 for Q1 2021 compared to net income and comprehensive income of $146,000 for Q1 2020 Q1 2021 EBITDA of $829,000, an increase of $159,000 compared to Q1 2020 EBITDA of $670,000 (see below for explanation and calculation of EBITDA) Q1 2021 EBITDAaL of $591,000, an increase of $175,000 compared to EBITDAaL of $416,000 for Q1 2020 (see below for explanation and calculation of EBITDAaL) Earnings per share of $0.02 in Q1 2021 compared to earnings per share of $0.01 in Q1 2020

ArcelorMittal S A : ArcelorMittal reports first quarter 2021 results

Luxembourg, May 6, 2021 - ArcelorMittal (referred to as "ArcelorMittal" or the "Company") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world's leading integrated steel and mining company

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021 Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and MELANI-01 in r/r MM patients in 15 US clinical centers Five partnered allogeneic CAR-T product candidates in clinical development through our collaborations with Allogene and Servier: UCART19/ALLO-501 and ALLO-501A in r/r NHL, ALLO-715 and ALLO-605 in r/r MM and ALLO-316 in advanced or metastatic clear cell renal cell carcinoma New collaboration with Cytovia Therapeutics, Inc. to develop TALEN ® Successful for UCART product candidates; On track to start production of UCART product candidates in 2021

PowerBand Solutions Inc : PowerBand s Month-Over-Month Growth Continues into April 2021

PowerBand Solutions Inc.: PowerBand s Month-Over-Month Growth Continues into April 2021 VANCOUVER, BC / ACCESSWIRE / May 6, 2021 / PowerBand Solutions Inc. (TSXV:PBX) (OTCQB:PWWBF) (FSE:1ZVA) ( PowerBand , PBX or the Company ), a comprehensive e-commerce solution transforming the online experience to sell, trade, lease, and finance vehicles, is pleased to announce the Company s April 2021 financial results demonstrate the continuation of strong month-over-month growth heading into the second quarter of 2021. April s gross sales activity totalled CDN $13.5 million, an increase of CDN $2.0 million compared to March of CDN $11.5 million, or 17 per cent. The total, year-to-date 2021 gross sales activity on the DRIVRZ platform is now CDN $39.8 million. (Non-IFRS measures). PowerBand s gross sales are the total dollar value of transactions from the various components of the

PolyMet Mining Corp : PolyMet Mining reports results for period ended March 31, 2021

PolyMet Mining Corp.: PolyMet Mining reports results for period ended March 31, 2021 St. Paul, Minnesota (Newsfile Corp. - May 6, 2021) - PolyMet Mining Corp. (TSX: POM) (NYSE American: PLM) today reports it has filed its financial results for the three months ended March 31, 2021 and provides a business update. The company made meaningful progress in litigation, continued its focus on optimization and engineering efforts related to the NorthMet Project, and maintained full compliance with all operating permits during the period, according to Jon Cherry, chairman, president and CEO. We are pleased with the rulings we received this spring from the Minnesota Supreme Court, which provide added clarity as we continue to work through the remaining legal challenges to our permits, Cherry said. We expect litigation will continue to at least year-end 2021.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.